Joshua Makower's Net Worth

Estimate Recalculated Jun 25, 2025 12:28AM EST

Who is Joshua Makower

Joshua Makower does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Cascadian Therapeutics, Inc., Nkarta, Inc., Berkshire Grey, Inc., Bright Health Group Inc., Verona Pharma plc, Monte Rosa Therapeutics, Inc., Robinhood Markets, Inc., AVEO PHARMACEUTICALS INC, Mirum Pharmaceuticals, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., GENOCEA BIOSCIENCES, INC., Metacrine, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., ARDELYX, INC., Savara Inc, Trevi Therapeutics, Inc., Annexon, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Regulus Therapeutics Inc., ARCA biopharma, Inc., Marker Therapeutics, Inc., Achaogen Inc, and IRIDEX CORP.

SEC CIK

Joshua Makower's CIK is 0001235952

Past Insider Trading and Trends

2022 was Joshua Makower's most active year for acquiring shares with 2 total transactions. Joshua Makower's most active month to acquire stocks was the month of September. 2022 saw Joshua Makower paying a total of $0.00 for 148,879 shares, this is the most they've acquired in one year.

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Desktop Metal, Inc.

Investor

Updated Jun 10, 2021


Form 4	-31.84%	-9.00M	—	—	Jun 10, 2021	19.27M	Disposition	—	Jun 08
Form 3	—	—	—	—	Dec 11, 2020	28.40M	—	—	—


Form 4	-100.00%	-10.88M	—	—	Mar 13, 2018	—	Disposition	—	Mar 09
Form 4	—	—	$3.30	$6.00M	Feb 22, 2018	10.88M	Options	—	Feb 20
Form 3	—	—	—	—	Feb 01, 2017	9.06M	—	—	—


Form 4	29.82%	666.67K	$18.00	—	Jul 16, 2020	2.90M	Purchase	—	Jul 14
Form 3	—	—	—	—	Jul 09, 2020	—	—	—	—


Form 4	76.29%	78.95M	$18.00	—	Jun 30, 2021	182.44M	Purchase	—	Jun 28
Form 3	—	—	—	—	Jun 24, 2021	46.86M	—	—	—


Form 4	-67.20%	-15.76M	$19.00	—	Jun 30, 2021	7.69M	Buy-Options	—	Jun 28
Form 3	—	—	—	—	Jun 23, 2021	—	—	—	—


Form 4	56.59%	1.43M	$5.25	$7.50M	Jun 22, 2020	3.95M	Purchase	—	Jun 19
Form 4	41.61%	8.70M	$0.58	$5.00M	Apr 08, 2019	29.59M	Purchase	—	Apr 08
Form 4	2.45%	500.00K	$1.55	$774.44K	Dec 21, 2018	20.90M	Purchase	—	Dec 20 - Dec 21
Form 4	0.30%	61.20K	$1.98	$121.08K	Dec 12, 2018	20.40M	Purchase	—	Dec 11
Form 4	0.85%	170.40K	$1.99	$338.35K	Dec 10, 2018	20.33M	Purchase	—	Dec 06 - Dec 10
Form 4	0.48%	96.40K	$1.98	$190.89K	Nov 30, 2018	20.16M	Purchase	—	Nov 28 - Nov 30
Form 4	0.85%	170.00K	$1.98	$336.11K	Nov 21, 2018	20.07M	Purchase	—	Nov 20
Form 4	6.42%	1.20M	$1.86	$2.24M	Nov 19, 2018	19.90M	Purchase	—	Nov 15 - Nov 19
Form 4	3.68%	663.72K	$2.26	$1.50M	Aug 22, 2018	18.70M	Purchase	—	Aug 21
Form 4	1.41%	250.60K	$1.96	$491.74K	Jul 20, 2018	18.03M	Purchase	—	Jul 18 - Jul 19
Form 4	1.09%	192.43K	$2.10	$404.08K	Jun 28, 2018	17.78M	Purchase	—	Jun 27 - Jun 28
Form 4	0.00%	275.00	$2.15	$591.25	May 30, 2018	17.59M	Purchase	—	May 30
Form 4	1.36%	236.48K	$2.13	$503.42K	May 21, 2018	17.59M	Purchase	—	May 17 - May 21
Form 4	0.41%	70.87K	$2.13	$151.25K	May 10, 2018	17.35M	Purchase	—	May 08
Form 4	5.63%	920.98K	$2.30	$2.12M	Apr 10, 2018	17.28M	Purchase	—	Apr 06 - Apr 10
Form 4	57.90%	6.00M	$0.50	$3.00M	Mar 29, 2017	16.36M	Purchase	—	Mar 28
Form 3	—	—	—	—	May 17, 2016	10.36M	—	—	—


Form 4	-85.99%	-25.70M	$15.00	—	Jul 24, 2019	4.19M	Buy-Options	—	Jul 22
Form 3	—	—	—	—	Jul 17, 2019	—	—	—	—


Form 4	-100.00%	-6.66M	$25.50	-$169.89M	Jun 07, 2019	—	Disposition	—	Jun 07
Form 3	—	—	—	—	Jan 02, 2019	6.66M	—	—	—


Form 4	-74.04%	-13.65M	$15.00	—	Apr 15, 2021	4.79M	Buy-Options	—	Apr 13
Form 3	—	—	—	—	Apr 08, 2021	—	—	—	—


Form 4	87.22%	6.30M	$1.19	$7.50M	Jul 28, 2020	13.53M	Purchase	—	Jul 24
Form 4	65.40%	2.86M	$3.50	$10.00M	Jun 25, 2019	7.23M	Purchase	—	Jun 24
Form 4	49.74%	12.44M	$0.30	$5.00M	Feb 19, 2019	37.44M	Purchase	—	Feb 14
Form 3	—	—	—	—	Jan 23, 2018	25.00M	—	—	—


Form 4	33.57%	769.23K	$13.00	—	Sep 22, 2020	3.06M	Purchase	—	Sep 18
Form 3	—	—	—	—	Sep 15, 2020	—	—	—	—


Form 4	11.43%	250.00K	$16.00	—	Jul 28, 2020	2.44M	Purchase	—	Jul 25 - Jul 28
Form 3	—	—	—	—	Jul 23, 2020	—	—	—	—


Form 4	—	74.07K	—	—	Oct 14, 2022	74.07K	Grant	—	Oct 12
Form 4	—	74.81K	—	—	Aug 25, 2022	74.81K	Grant	—	Aug 23
Form 4	-30.67%	-2.00M	—	—	May 26, 2021	4.52M	Disposition	—	May 24
Form 4	42.40%	1.94M	$18.00	—	Oct 22, 2020	6.52M	Purchase	—	Oct 20
Form 4	—	6.67K	—	—	Oct 19, 2020	6.67K	Grant	—	Oct 15
Form 3	—	—	—	—	Oct 15, 2020	—	—	—	—


Form 4	12.98%	400.00K	$6.25	$2.50M	Dec 09, 2019	6.56M	Grant	—	Dec 09
Form 4	15.63%	833.33K	$4.00	$3.33M	May 30, 2018	6.16M	Grant	—	May 25
Form 4	40.15%	1.53M	$8.73	$13.33M	Jul 20, 2016	5.33M	Purchase	—	Jul 18
Form 4	35.67%	1.00M	$10.00	$10.00M	Jan 14, 2016	3.80M	Purchase	—	Jan 13
Form 3	—	—	—	—	Jan 14, 2016	2.80M	—	—	—


Form 4	-0.01%	-564.00	$2.66	-$0.24	Apr 13, 2020	5.94M	Sale	—	Apr 03
Form 4	-74.04%	-12.66M	$10.00	—	May 13, 2019	4.44M	Buy-Options	—	May 09
Form 3	—	—	—	—	May 07, 2019	—	—	—	—


Form 4	15.87%	588.24K	$17.00	—	Jul 01, 2020	4.29M	Purchase	—	Jun 30
Form 3	—	—	—	—	Jun 25, 2020	—	—	—	—


Form 4	—	—	—	—	Mar 16, 2021	—	—	—	—
Form 4	482.18%	9.90M	$1.90	$5.00M	Dec 07, 2020	11.95M	Purchase	—	Dec 04
Form 4	—	9.91M	$3.40	$7.13M	Dec 26, 2019	15.92M	Purchase	—	Dec 24
Form 4	556.60%	5.10M	$3.28	$4.46M	May 09, 2019	6.01M	Purchase	—	May 07
Form 3	—	—	—	—	Jul 31, 2017	10.99M	—	—	—


Form 4	-100.00%	-1.46M	$0.50	-$731.27K	Feb 27, 2018	—	Sale	—	Feb 26
Form 3	—	—	—	—	Jun 17, 2015	10.22M	—	—	—


Form 4	114.29%	5.71M	$1.75	$10.00M	Mar 18, 2021	10.71M	Purchase	—	Mar 16
Form 3	—	—	—	—	Oct 18, 2018	5.00M	—	—	—


Form 4	—	3.75K	—	—	Jul 02, 2004	3.75K	Grant	—	Jul 01
Form 4	—	—	—	—	Jul 23, 2003	—	—	—	—
Form 4	—	—	—	—	Jul 02, 2003	—	—	—	—

Joshua Makower's Net Worth

Who is Joshua Makower

SEC CIK

Past Insider Trading and Trends

Desktop Metal, Inc.

Cascadian Therapeutics, Inc.

Nkarta, Inc.

Berkshire Grey, Inc.

Bright Health Group Inc.

Verona Pharma plc

Monte Rosa Therapeutics, Inc.

Robinhood Markets, Inc.

AVEO PHARMACEUTICALS, INC.

Mirum Pharmaceuticals, Inc.

Nightstar Therapeutics plc

Reneo Pharmaceuticals, Inc.

GENOCEA BIOSCIENCES, INC.

Metacrine, Inc.

Inozyme Pharma, Inc.

Millendo Therapeutics, Inc.

Eargo, Inc.

ARDELYX, INC.

Savara Inc

Trevi Therapeutics, Inc.

Annexon, Inc.

Akouos, Inc.

Black Diamond Therapeutics, Inc.

Regulus Therapeutics Inc.

ARCA biopharma, Inc.

Marker Therapeutics, Inc.

Achaogen Inc

IRIDEX CORP